Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients

Psoriasis is a chronic, multisystem, inflammatory disease that affects approximately 1% of children, with onset most common during adolescence. This guideline addresses important clinical questions that arise in psoriasis management and provides evidence-based recommendations. Attention will be give...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Journal of the American Academy of Dermatology Ročník 82; číslo 1; s. 161 - 201
Hlavní autoři:	Menter, Alan, Cordoro, Kelly M., Davis, Dawn M.R., Kroshinsky, Daniela, Paller, Amy S., Armstrong, April W., Connor, Cody, Elewski, Boni E., Gelfand, Joel M., Gordon, Kenneth B., Gottlieb, Alice B., Kaplan, Daniel H., Kavanaugh, Arthur, Kiselica, Matthew, Kivelevitch, Dario, Korman, Neil J., Lebwohl, Mark, Leonardi, Craig L., Lichten, Jason, Lim, Henry W., Mehta, Nehal N., Parra, Sylvia L., Pathy, Arun L., Farley Prater, Elizabeth A., Rupani, Reena N., Siegel, Michael, Stoff, Benjamin, Strober, Bruce E., Wong, Emily B., Wu, Jashin J., Hariharan, Vidhya, Elmets, Craig A.
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States Elsevier Inc 01.01.2020
Témata:	clinical guidelines for psoriasis comorbidities dermatology guidelines pediatric pediatric psoriasis psoriasis psoriasis guidelines skin disease UVB UVA FDA NAFLD PPD PASI 75 TNF pediatric BSA LDL PUVA pediatric psoriasis guidelines BMI PSA UV GI PASI IL OR AAD AOR CI skin disease clinical guidelines for psoriasis aHR ICD QOL AAP dermatology CDLQI comorbidities NB psoriasis psoriasis guidelines HPA TCI
ISSN:	0190-9622, 1097-6787, 1097-6787
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Popis
Shrnutí:	Psoriasis is a chronic, multisystem, inflammatory disease that affects approximately 1% of children, with onset most common during adolescence. This guideline addresses important clinical questions that arise in psoriasis management and provides evidence-based recommendations. Attention will be given to pediatric patients with psoriasis, recognizing the unique physiology, pharmacokinetics, and patient-parent-provider interactions of patients younger than 18 years old. The topics reviewed here mirror those discussed in the adult guideline sections, excluding those topics that are irrelevant to, or lack sufficient information for, pediatric patients.
Bibliografie:	ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 ObjectType-Instructional Material/Guideline-3 content type line 23
ISSN:	0190-9622 1097-6787 1097-6787
DOI:	10.1016/j.jaad.2019.08.049